MACRA #410- Psoriasis Clinical Response to Systemic Medications EZDERM Support L1 January 03, 2025 13:58 Updated Follow Additional Resources: Healthmonis Detailed Measure Description Related articles Measure #176- Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy MACRA # 485 & 486- Psoriasis/Dermatitis Improvement in Patient-Reported Itch Severity New Quality Measures for 2024 (137, 176, 410, 485, 486, 487) EZDERM + Healthmonix: Reporting Mips in 2024 BSA-PASI-PGA Comments 0 comments Please sign in to leave a comment.
Comments
0 comments
Please sign in to leave a comment.